Literature DB >> 30021369

KGF inhibits hypoxia-induced intestinal epithelial cell apoptosis by upregulating AKT/ERK pathway-dependent E-cadherin expression.

Yujiao Cai1, Wensheng Wang2, Yuan Qiu2, Min Yu2, Jiuheng Yin2, Hua Yang3, Jie Mei2.   

Abstract

OBJECTIVE: Intestinal ischemia-reperfusion (I/R) causes direct cellular damage, and the potential injury to the mucosal structure and barrier function. Keratinocyte growth factor (KGF) is highly expressed in gastrointestinal tract and exerts beneficial effects for intestinal epithelial growth and maintenance. E-cadherin plays an important role in intestinal epithelium renewal. However, the regulatory role of KGF on E-cadherin levels and I/R-induced apoptosis remain to be explored. The present study aimed to identify the effect of KGF on E-cadherin expression and I/R-induced intestinal epithelial cell apoptosis.
METHODS: Caco2 cells were treated with KGF (100 ng/ml) for 0, 4, 8, 12, and 24 h under hypoxia or normoxia. An E-cadherin-knockdown model was successfully established by treatment with E-cadherin RNAi. Western blotting and immunofluorescence labeling were performed to assess E-cadherin expression. Levels of PI3K|[sol]|Akt/mitogen-activated protein kinases (MAPKs), phosphoinositide 3-kinase (PI3K|[sol]|Akt)/PI3K|[sol]|Akt pathway-related proteins, and apoptosis-related proteins were also detected by western blot. Finally, a rat model of acute intestinal I/R was established and treated with KGF. Hematoxylin-eosin (HE), terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL), and immunofluorescence staining were performed to detect morphological changes in intestinal mucosal epithelium and Caco2 cell apoptosis.
RESULTS: KGF enhanced E-cadherin expression in differentiated intestinal epithelial cells under hypoxia via AKT/extracellular-regulated kinase (ERK) pathway regulation. In vitro, E-cadherin downregulation aggravates hypoxia-induced intestinal epithelial cell apoptosis. In the rat model, KGF increased E-cadherin expression, which was associated with the reduced apoptosis.
CONCLUSIONS: KGF exerts protective effects on intestinal epithelial cells under hypoxia by elevating E-cadherin levels or activating AKT/ERK signaling.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  AKT/ERK pathway; Apoptosis; E-cadherin; Hypoxia; Intestinal ischemia-reperfusion; KGF

Mesh:

Substances:

Year:  2018        PMID: 30021369     DOI: 10.1016/j.biopha.2018.06.091

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  8 in total

1.  The role of neutrophil extracellular traps and TLR signaling in skeletal muscle ischemia reperfusion injury.

Authors:  Nicole J Edwards; Charles Hwang; Simone Marini; Chase A Pagani; Philip J Spreadborough; Cassie J Rowe; Pauline Yu; Annie Mei; Noelle Visser; Shuli Li; Geoffrey E Hespe; Amanda K Huber; Amy L Strong; Miriam A Shelef; Jason S Knight; Thomas A Davis; Benjamin Levi
Journal:  FASEB J       Date:  2020-10-22       Impact factor: 5.191

2.  Durability of and role of AKT in FGF7p urothelial protection against cyclophosphamide.

Authors:  Sridhar Tatarao Narla; Lori Rice; David Ostrov; Daniel Scott Bushnell; Joanne Lindsey Duara; Carlton Matthew Bates
Journal:  Physiol Rep       Date:  2022-06

3.  Down-regulating microRNA-20a regulates CDH1 to protect against cerebral ischemia/reperfusion injury in rats.

Authors:  Chun-Chun Yang; Xiang-Pin Wei; Xian-Ming Fu; Ling-Tao Qian; Lan-Jun Xie; Hong-Bo Liu; Gang Li; Xin-Gang Li; Xian-Wei Zeng
Journal:  Cell Cycle       Date:  2020-12-19       Impact factor: 4.534

4.  AKT Signaling Downstream of KGF Is Necessary and Sufficient for Blocking Cyclophosphamide Bladder Injury.

Authors:  Sridhar T Narla; Daniel S Bushnell; Joanne L Duara; Carlton M Bates
Journal:  Am J Pathol       Date:  2022-01-19       Impact factor: 5.770

5.  Hypoxic Cell-Derived Extracellular Vesicles Aggravate Rectal Injury Following Radiotherapy via MiR-122-5p.

Authors:  Yiqing Xu; Yulong Ge; Xuming Chen; Yingzi Zhang; Huanliang Chen; Dongli Liu; Yue Lu; Yong Liu; Wenzhi Tu
Journal:  Front Cell Dev Biol       Date:  2022-04-26

6.  Artemisinin analog SM934 alleviates epithelial barrier dysfunction via inhibiting apoptosis and caspase-1-mediated pyroptosis in experimental colitis.

Authors:  Meijuan Shao; Yuxi Yan; Fenghua Zhu; Xiaoqian Yang; Qing Qi; Fangming Yang; Tingting Hao; Zemin Lin; Peilan He; Yu Zhou; Wei Tang; Shijun He; Jianping Zuo
Journal:  Front Pharmacol       Date:  2022-09-01       Impact factor: 5.988

7.  Insulin-producing organoids engineered from islet and amniotic epithelial cells to treat diabetes.

Authors:  Fanny Lebreton; Vanessa Lavallard; Kevin Bellofatto; Romain Bonnet; Charles H Wassmer; Lisa Perez; Vakhtang Kalandadze; Antonia Follenzi; Michel Boulvain; Julie Kerr-Conte; David J Goodman; Domenico Bosco; Thierry Berney; Ekaterine Berishvili
Journal:  Nat Commun       Date:  2019-10-03       Impact factor: 14.919

8.  Keratinocyte Growth Factor-1 Protects Radioiodine-Induced Salivary Gland Dysfunction in Mice.

Authors:  Jeong Mi Kim; Mi Eun Choi; Seok-Ki Kim; Ji Won Kim; Young-Mo Kim; Jeong-Seok Choi
Journal:  Int J Environ Res Public Health       Date:  2020-08-31       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.